CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Press Release: The Rheumatology Network for Dorset x My Arthritis app
15 Dec 2021
Ampersand Health has today announced a partnership with Our Dorset Digital and Rheumatology Dorset to roll out My Arthritis App across the county,...
Ampersand Health Featured in Spoonie Magazine
20 May 2021
The article, titled: ‘Do More and Feel Better? Let’s Talk About Pacing.’ gave tips and advice for people living with chronic illnesses like inflammatory...
[Podcast]: The AHSN discusses the innovations that are helping the NHS manage the Covid19 outbreak
04 Aug 2020
Ampersand Health Featured in BMJ
22 Jun 2023
Our work on patient initiated follow-up using our My IBD Care app, along with self-monitoring of calprotectin through our CalproSmart™ ™ integration,...
Press Release: London NHS CCGs Discuss Benefits of Using New HealthSuite App from Ampersand
19 Jul 2018
Clinical Commissioning Groups (CCGs) from across London have expressed interest in trialling and adopting digital self-management platform HealthSuite from...
